Bullfrog AI Holdings, Inc. (NASDAQ:BFRG) experienced a notable decrease in short interest during the month of September, according to recent reports. The short interest as of September 15th stood at 199,600 shares, marking a decline of 30.1% from the previous month’s total of 285,500 shares. This accounts for approximately 3.8% of the company’s stock being short sold. With an average daily trading volume of 202,100 shares, the days-to-cover ratio currently stands at 1.0 days.
Several prominent institutional investors have recently made changes to their positions in Bullfrog AI. Fortem Financial Group LLC acquired a new stake in the company during the first quarter, valued at $171,000. Renaissance Technologies LLC also purchased a new stake in Bullfrog AI during the second quarter, amounting to $34,000. Additionally, XTX Topco Ltd bought a new stake in the company during the same period, worth $32,000. Hedge funds and other institutional investors now own 0.96% of Bullfrog AI’s stock.
On Friday, NASDAQ:BFRG saw a slight increase of $0.02, reaching $2.98 per share. The stock had a trading volume of 120,441 shares, compared to its average volume of 983,709. Over the past year, Bullfrog AI’s stock has ranged from a low of $1.43 to a high of $8.35. Currently, the stock has a fifty-day simple moving average of $2.63 and a two-hundred-day simple moving average of $2.73. With a market capitalization of $23.40 million, the company has a P/E ratio of -3.39 and a beta of -0.20.
Bullfrog AI Holdings, Inc. operates as a digital biopharmaceutical company in the United States, focusing on artificial intelligence and machine learning (AI/ML) analysis of medical and healthcare data sets. The company’s analytical AI/ML platform, bfLEAP, is designed for the analysis of preclinical and clinical data.